Cancer stem cell theory: Pathologists' considerations and ruminations about wasting time and wrong evaluations [1]

Journal of Clinical Pathology

Volumn 57, Issue 7, 2004, Pages 782-

  Nuciforo, P ^a   Fraggetto, F ^b  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b CANNIZZARO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TUMOR MARKER;

BREAST CARCINOMA; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CELL POPULATION; CELL STRUCTURE; DIAGNOSTIC ACCURACY; DNA MICROARRAY; EVALUATION; GENE EXPRESSION PROFILING; GENE TARGETING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MEDICAL PRACTICE; METASTASIS; MOLECULAR CLONING; MOLECULAR DYNAMICS; PATHOLOGIST; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RNA TRANSLATION; SAMPLING; SCREENING; STEM CELL; TIME; TREATMENT PLANNING; TUMOR DIFFERENTIATION;

GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS; PATHOLOGY, CLINICAL; TUMOR STEM CELLS;

EID: 3142556128     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11.
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003;100:3983-8.
3. Von de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
4. Orr MS, Scherf U. Large-scale gene expression analysis in molecular target discovery. Leukemia 2002;16:473-7.
5. Carney DN. Lung cancer - time to move on from chemotherapy. N Engl J Med 2002;346:126-8.
6. Dick JH. Breast cancer stem cells revealed. Proc Natl Acad Sci U S A 2003;100:3547-9.